Foundation Programs
MAFP Research Network
For many years, the Minnesota Academy of Family
Physicians (MAFP) Foundation has supported the MAFP Research
Network’s practice-based research efforts.
The partnership between the MAFP Foundation and
the MAFP Research Network is very important which is why the MAFP
Foundation is awarding a $5,000 grant to the MAFP Research Network
in 2008 in support of their efforts.
The Research Network is a nonprofit
organization of family physicians and other health providers that
promotes and conducts practice-based research to further the
practice of family medicine. Membership includes more than 200
family physicians, residents and allied professionals representing
more than 100 medical practices located primarily in Minnesota.
The MAFP Research Network’s Studies:
For a detailed description please visit
here.
- ACCORD is an acronym for Action to
Control Cardiovascular Risk in Diabetes.
The aim is to test
whether intensive control of blood glucose (A1c less than 6) is more
effective in reducing cardiovascular events than conventional
control.
The electronic Primary Care Research
Network (ePCRN)
The ePCRN is designed to support primary care
providers in conducting clinical research in their practices and to
provide secure, cutting-edge technology along with training, support
and technical assistance. This technology will also enable
practices to create disease registries and report quality
indicators, and to better communicate and coordinate activities
among practices.
The Asthma Apgar
Pilot studies with the Asthma APGAR are completed. The study,
funded by AHRQ, was intended to validate and improve a tool used by
practices to assess their current asthma care and to design new
systems for collecting information from people with asthma about
current asthma control.
Improving Diabetes through Primary Care
Translation (IMPACT)
IMPACT involved 24 primary care clinics and
more than 8,500 patients with diabetes. This intervention model was
developed in MAFPRN and appears to be effective in changing
physician behavior, enhancing practice performance, and improving
clinical outcomes in diabetes and hypertension.
Atherothrombosis Intervention in
Metabolic Syndrome
As a clinical center for the AIM-HIGH Trial, testing will be done to
determine whether the combination of niacin and simvastatin lowers
the risk of heart attacks and strokes more than just taking
simvastatin alone.
For more information on MAFP Foundation Programs, contact:
Lynn Balfour, MAFP Foundation Executive Director
(952) 542-0130, (800) 999-8198, or e-mail
foundation@mafp.org
